Clinical Trials Directory

Trials / Completed

CompletedNCT02467348

Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.

To Study the Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Institute of Liver and Biliary Sciences, India · Academic / Other
Sex
All
Age
12 Years – 75 Years
Healthy volunteers
Not accepted

Summary

All consecutive patients admitted in ILBS from MAY 2015 to DECEMBER 2016.ACLF (Acute on chronic Liver Failure). ACLF will be randomize into Group 1: MVP (Modest Volume Paracentesis) OF Less than 5 liters with IV albumin at a dose 8 gms/L of ascitic fluid Group 2: MVP (Modest Volume Paracentesis) of Less than 5 liters without albumin

Conditions

Interventions

TypeNameDescription
DRUGAlbuminIntravenous albumin 8 gms/L of ascitic fluid
DRUGAscitic fluid

Timeline

Start date
2015-03-15
Primary completion
2017-01-31
Completion
2017-01-31
First posted
2015-06-10
Last updated
2017-11-28

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02467348. Inclusion in this directory is not an endorsement.